1. Brett, J, Karanges, EA, Daniels, B, et al. Psychotropic medication use in Australia, 2007 to 2015: changes in annual incidence, prevalence and treatment exposure. Aust N Z J Psychiatry 2017; 51: 990–999.
Google Scholar | SAGE Journals | ISI2. McCann, TV, Clark, E, Lu, S. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia. J Adv Nurs 2009; 65: 534–543.
Google Scholar | Crossref | Medline | ISI3. McIntyre, RS, Jerrell, JM. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. Arch Pediatr Adolesc Med 2008; 162: 929–935.
Google Scholar | Crossref | Medline4. Morrato, EH, Newcomer, JW, Allen, RR, et al. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data. J Clin Psychiatry 2008; 69: 316–322.
Google Scholar | Crossref | Medline | ISI5. Young, SL, Taylor, M, Lawrie, SM. “First do no harm.” A systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol 2015; 29: 353–362.
Google Scholar | SAGE Journals | ISI6. Flanagan, RJ, Dunk, L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol 2008; 23(Suppl. 1): S27–S41.
Google Scholar | Crossref | Medline | ISI7. Mattson, ME, Albright, VA, Yoon, J, et al. Emergency department visits involving misuse and abuse of the antipsychotic quetiapine: results from the Drug Abuse Warning Network (DAWN). Subst Abuse 2015; 9: SART.S22233.
Google Scholar8. Morin, AK. Possible intranasal quetiapine misuse. Am J Health Syst Pharm 2007; 64: 723–725.
Google Scholar | Crossref | Medline9. Malekshahi, T, Tioleco, N, Ahmed, N, et al. Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse. J Subst Abuse Treat 2015; 48: 8–12.
Google Scholar | Crossref | Medline | ISI10. Klein, L, Bangh, S, Cole, JB. Intentional recreational abuse of quetiapine compared to other second-generation antipsychotics. West J Emerg Med 2017; 18: 243–250.
Google Scholar | Crossref | Medline11. Lertxundi, U, Hernandez, R, Medrano, J, et al. Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation? Int Clin Psychopharmacol 2018; 33: 56–58.
Google Scholar | Crossref | Medline12. Raschi, E, Poluzzi, E, Godman, B, et al. Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. PLoS One 2013; 8: e81208.
Google Scholar | Crossref | Medline | ISI13. Poluzzi, E, Raschi, E, Koci, A, et al. Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf 2013; 36: 467–479.
Google Scholar | Crossref | Medline14. Raschi, E, Poluzzi, E, Salvo, F, et al. The contribution of national spontaneous reporting systems to detect signals of torsadogenicity: issues emerging from the ARITMO project. Drug Saf 2016; 39: 59–68.
Google Scholar | Crossref | Medline15. Montastruc, F, Palmaro, A, Bagheri, H, et al, Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: a pharmacoepidemiological-pharmacodynamic study in VigiBase. European Neuropsychopharmacology 2015; 25: 1556–65.
Google Scholar | Crossref | Medline16. Minjon, L, van den Ban, E, de Jong, E, et al, Heerdink, ER. Reported adverse drug reactions in children and adolescents treated with antipsychotics. Journal of child and adolescent psychopharmacology 2019; 29: 124–32.
Google Scholar | Crossref | Medline17. Nguyen, T.T.H, Pariente, A, Montastruc, JL, et al, An original pharmacoepidemiological–pharmacodynamic method: application to antipsychotic-induced movement disorders. British journal of clinical pharmacology 2017; 83: 612–622.
Google Scholar | Crossref | Medline18. Liu, F, Jagannatha, A, Yu, H. Towards drug safety surveillance and pharmacovigilance: current progress in detecting medication and adverse drug events from electronic health records. Drug Saf 2019; 42: 95–97.
Google Scholar | Crossref | Medline19. Chen, EY, Diug, B, Bell, JS, et al. Spontaneously reported haemorrhagic adverse events associated with rivaroxaban and dabigatran in Australia. Ther Adv Drug Saf 2016; 7: 4–10.
Google Scholar | SAGE Journals | ISI20. Sagreiya, H, Chen, Y-R, Kumarasamy, NA, et al. Differences in antipsychotic-related adverse events in adult, pediatric, and geriatric populations. Cureus 2017; 9: e1059.
Google Scholar | Medline21. Seida, JC, Schouten, JR, Boylan, K, et al. Antipsychotics for children and young adults: a comparative effectiveness review. Pediatrics 2012; 129: e771–e784.
Google Scholar | Crossref | Medline | ISI22. Kimura, G, Kadoyama, K, Brown, JB, et al. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database. Int J Med Sci 2015; 12: 135–140.
Google Scholar | Crossref | Medline23. Murri, MB, Bugliani, M, Calcagno, P, et al. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D 2015; 15: 45–62.
Google Scholar | Crossref | Medline24. Beach, SR, Celano, CM, Noseworthy, PA, et al. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics 2013; 54: 1–3.
Google Scholar | Crossref | Medline | ISI25. Bellissima, BL, Tingle, MD, Cicović, A, et al. A systematic review of clozapine-induced myocarditis. Int J Cardiol 2018; 259: 122–129.
Google Scholar | Crossref | Medline26. Strålin, P, Hetta, J. 5-years follow-up of antipsychotic medication and hospitalizations after first episode hospital-treated psychosis in a Swedish nation-wide cohort. Eur Psychiatry 2017; 41: S99.
Google Scholar | Crossref27. Vandenberk, B, Vandael, E, Robyns, T, et al. Which QT correction formulae to use for QT monitoring? J Am Heart Assoc 2016; 5: e003264.
Google Scholar | Crossref | Medline28. Pringsheim, T, Gardner, D, Addington, D, et al. The assessment and treatment of antipsychotic-induced akathisia. Can J Psychiatry 2018; 63: 719–729.
Google Scholar | SAGE Journals | ISI29. Rojo, LE, Gaspar, PA, Silva, H, et al. Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology. Pharmacol Res 2015; 101: 74–85.
Google Scholar | Crossref | Medline | ISI30. Ralph, SJ, Espinet, AJ. Increased all-cause mortality by antipsychotic drugs: updated review and meta-analysis in dementia and general mental health care. J Alzheimers Dis Rep 2018; 2: 287–312.
Google Scholar31. Methling, M, Krumbiegel, F, Hartwig, S, et al. Toxicological findings in suicides–frequency of antidepressant and antipsychotic substances. Forensic Sci Med Pathol 2019; 15: 23–30.
Google Scholar | Crossref | Medline32. Raffin, M, Gianitelli, M, Consoli, A, et al. Management of adverse effects of second-generation antipsychotics in youth. Curr Treat Options Psych 2014; 1: 84–105.
Google Scholar | Crossref